Stephen Spearman, Ph.D., MBA, President
Steve is responsible for our business performance, including delivery of all manufacturing, financial and regulatory. Steve has over 30 years of experience including many positions of senior and executive management. His previous experience includes seven years in development and manufacturing in Switzerland for Ciba-Geigy and almost 15 years with Pharmacopeia, Inc, in the manufacture of Biologics. His responsibilities with Pharmacopeia, Inc began as Executive VP of Operations and he later became Chief Operating Officer for the company.
David Patterson, M.A., Senior Vice President Quality and Regulatory
David is responsible for directing the development, implementation and maintenance of quality control, quality assurance and regulatory systems and activities across both sites. David has 35 years of experience in the pharmaceutical and medical device business, operating in the United States and Europe for various companies. During his tenure at these positions he has been responsible for the compliance and regulatory approval of several facility expansions and successful inspections by the US FDA, Canadian, European, Japanese and several South American regulatory agencies. Dave is an ASQ certified Quality Engineer and Quality Auditor.
Steve Bagshaw, Managing Director
Steve has nearly 25 years' experience operating in the UK and US for Fujifilm Diosynth Biotechnologies, and its predecessor companies MSD BioManufacturing Network, Avecia, Zeneca Specialties and ICI. In his current role Steve is responsible for the business performance of Fujifilm Diosynth Biotechnologies Billingham site, including delivery of all financial and regulatory target. Steve's previous experience includes three years as President of Image Polymers Inc, a joint venture between Mitsui Chemicals and Avecia. Before that he held a number of Operations Management posts and was also the company's Safety Health & Environment Manager.
Stephen Taylor, Ph.D., Senior Vice President and Commercial Director
Steve is director responsible for business development. In the period 1996 - 2004 as General Manager he led the creation and growth of the Avecia Biologics business. Steve has been involved with various industry groups including chairing the manufacturing committee of the UK Biotechnology Industry Association (BIA) 2001–2004. He led the UK government team seeking expansion of UK bioscience, is a member of the UK Bioscience Strategy Council and now chairs the UK bio-processing strategy group directing implementation of the strategic plan for UK biopharmaceutical development.
Mark Carver, Ph.D., Senior Vice President R&D and Innovation
Mark Carver is responsible for all Research & Development activities across both sites. He has over 20 years' expertise in designing research and development programmes to develop scaleable and validated manufacturing processes for recombinant protein products based on microbial expression in bacterial, yeast and filamentous fungal systems.
Martin Meeson, Senior Vice President Finance & IT
Martin Meeson is responsible for all Finance and IT activities at both sites. Prior to joining the company in 2007, Martin was for four years Finance Director at Oxford Chemicals responsible for all aspects of Finance, IT and Purchasing. Prior to joining Oxford Chemicals, Martin held a number of relevant roles between August 2000 and June 2003 at Hibernia Foods and prior to that at ICI/DuPont and KPMG.
John Foy, MBA, Vice President Business Development and Logistics
John has over 20 years of experience in Engineering, Maintenance, Operations, Business Development and Logistics. He has been part of the RTP team for the past 10 years contributing to the growth and success of the 3rd party manufacturing business through development of robust business practices pertaining to program management, client proposal and contract development and operations planning.